Market Cap | 1.35M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -382.25k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 107.00% |
Sales | 50.95k | PEG | - | EPS past 5Y | - | 200D Avg Chg | 130.00% |
Dividend | N/A | Price/Book | EPS next 5Y | - | 52W High Chg | -62.00% | |
Recommedations | - | Quick Ratio | 0.00 | Shares Outstanding | 79.60M | 52W Low Chg | 1,033.00% |
Insider Own | - | ROA | -1.50% | Shares Float | - | Beta | -5.86 |
Inst Own | - | ROE | -23.90% | Shares Shorted/Prior | -/- | Price | 0.02 |
Gross Margin | 154.66% | Profit Margin | - | Avg. Volume | 35,024 | Target Price | - |
Oper. Margin | 810.61% | Earnings Date | - | Volume | 100 | Change | -15.00% |
Shanghai Yutong Pharma, Inc. engages in the development, manufacturing, and commercialization of traditional Chinese herbal medicines and biological pharmaceuticals in the People's Republic of China. Its products primarily include Qilisheng a product formulated to be a general health enhancer by fortifying the immune system; Qi-ju-di-huang, an oral solution that protects the kidney and the liver; Qing-re-jie-du, an oral solution that reduces fever and relieves heat; Sheng-mai-yin, a solution that protects energy and enhances body fluids; Xiao-qing-long, an oral solution that relieves cough and dyspnea; Shen-bao, a syrup for the treatment of impotence and spermatorrhoea; Ban-xia, a syrup that relieves cough; and Gan-mao-zhi-ke, a syrup that relieves flu symptoms, cough, and nasal congestion. It also offers Ban-lan-gen that relieves cold and flu symptoms; Gan-mao-qing-re that relieves minor body aches and pains, and reduces fever; Huang-dan-yin-chen used in the treatment for jaundice infection hepatitis; and Liu-shen-qu for treatment of vomitings and dysentery. It offers its products to distributors on a wholesale basis. The company is based in Shanghai, China.